Condition: Psychosis


A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis

Abstract Emotional dysregulation and anxiety are common in people at clinical high risk for psychosis (CHR) and are associated with altered neural responses to emotional stimuli in the striatum and…

Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis

Abstract   Rationale: Stress is a risk factor for psychosis and treatments which mitigate its harmful effects are needed. Cannabidiol (CBD) has antipsychotic and anxiolytic effects.   Objectives: We investigated whether CBD…